for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bio-Thera Solutions Ltd

688177.SS

Latest Trade

23.81CNY

Change

0.34(+1.45%)

Volume

1,234,125

Today's Range

23.33

 - 

24.28

52 Week Range

21.82

 - 

73.99

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
23.47
Open
23.33
Volume
1,234,125
3M AVG Volume
26.19
Today's High
24.28
Today's Low
23.33
52 Week High
73.99
52 Week Low
21.82
Shares Out (MIL)
414.08
Market Cap (MIL)
9,718.46
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Biogen And Bio-Thera Solutions Announce Commercialization And License Agreement For Proposed Biosimilar Currently In Phase 3 With Potential To Treat Moderate To Severe Rheumatoid Arthritis

Bio-Thera Solutions' 2020 Net Loss Narrows To 513.2 Mln Yuan

Bio-Thera Solutions' Prelim 2020 Net Loss Narrows

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bio-Thera Solutions Ltd

Bio-Thera Solutions, Ltd. is a China-based company mainly engaged in the research and development of innovative drugs and biosimilars. The Company is committed to the development of a new generation of antibody drugs to treat cancer, autoimmune diseases, cardiovascular diseases and other major diseases that endanger human life and health. The Company's main products include adalimumab BAT1406, bevacizumab BAT1706, BAT8001, tocilizumab BAT1806, batifaban BAT2094, BAT8003 and so on.

Industry

Biotechnology & Drugs

Contact Info

+86.20.32203220

https://www.bio-thera.com/

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
52.54
Price To Book (MRQ)
4.85
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-38.86
Return on Equity (TTM)
-30.12

Latest News

Latest News

BRIEF-Bio-Thera Solutions' H1 Net Loss Narrows To 243.8 M;n Yuan

* SAYS H1 NET LOSS NARROWS TO 243.8 MILLION YUAN ($35.41 million) FROM 715.1 MILLION YUAN YEAR EARLIER Source text in Chinese: https://bit.ly/34Ep88u Further company coverage: ($1 = 6.8841 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Bio-Thera Solutions Plans To Issue H-Shares And List In Hong Kong

* SAYS IT PLANS TO ISSUE H-SHARES AND LIST IN HONG KONG STOCK EXCHANGE Source text in Chinese: https://bit.ly/3d6AJhl Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Bio-Thera Solutions' Net Losses Widen In 2019, Q1

* SAYS 2019 NET LOSS WIDENS TO 1.0 BILLION YUAN ($141.33 million) FROM 553.1 MILLION YUAN YEAR EARLIER

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up